Gastrointestinal Stromal Tumour (GIST) Research 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
Malignant solitary fibrous tumor of the urinary bladder progressing to widespread metastases and death: a rare case report and literature review
Int J Clin Exp Pathol. 2023 Sep 15;16(9):243-251. eCollection 2023.ABSTRACTSolitary fibrous tumor (SFT) of the urinary bladder has been rarely reported and malignant bladder SFT is even rarer. Here we present a case of an African-American male with SFT of the urinary bladder (intermediate risk) initially treated by cystoprostatectomy at the age of 59 years. Eight years later, he developed recurrence with widespread metastases to the liver, lungs, and abdominal cavity. He then received temozolomide and bevacizumab with good disease control. However, treatment was paused due to declining performance status. Follow-up at 1 ye...
Source: International Journal of Clinical and Experimental Pathology - October 11, 2023 Category: Pathology Authors: Hatice B Zengin Michael McCabe Bahadir Yildiz Tiffany J Sheganoski Caroline R Dignan Aaron R Huber Hiroshi Miyamoto Ying Wang Source Type: research
